Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Amyotrophic lateral sclerosis and gene therapy

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Get just this article for as long as you need it


Prices may be subject to local taxes which are calculated during checkout


  1. Zamore PD and Haley B (2005) Ribo-gnome: the big world of small RNAs. Science 309: 1519–1524

    Article  CAS  Google Scholar 

  2. Thakker DR et al. (2004) Neurochemical and behavioral consequences of widespread gene knockdown in the adult mouse brain by using nonviral RNA interference. Proc Natl Acad Sci USA 101: 17270–17275

    Article  CAS  Google Scholar 

  3. Dorn G et al. (2004) siRNA relieves chronic neuropathic pain. Nucleic Acids Res 32: e49

    Article  Google Scholar 

  4. Clement AM et al. (2003) Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 302: 113–117

    Article  CAS  Google Scholar 

  5. Boillee S et al. (2006) Onset and progression in inherited ALS determined by motor neurons and microglia. Science 312: 1389–1392

    Article  CAS  Google Scholar 

  6. Ralph GS et al. (2005) Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model. Nat Med 11: 429–433

    Article  CAS  Google Scholar 

  7. Raoul C et al. (2005) Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS. Nat Med 11: 423–428

    Article  CAS  Google Scholar 

  8. Miller TM et al. (2005) Virus-delivered small RNA silencing sustains strength in amyotrophic lateral sclerosis. Ann Neurol 57: 773–776

    Article  CAS  Google Scholar 

  9. Grimm D et al. (2006) Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature 441: 537–541

    Article  CAS  Google Scholar 

  10. Smith R et al. (2006) Antisense oligonucleotide therapy for neurodegenerative disease. J Clin Invest, in press

    Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Don W Cleveland.

Ethics declarations

Competing interests

DW Cleveland and RA Smith have a consulting agreement with Isis Pharmaceutical Corporation. Along with ongoing compensation, they and their institutional employers could materially benefit if a therapeutic for amyotrophic lateral sclerosis results from their work. TM Miller declared he has no competing interests.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Miller, T., Smith, R. & Cleveland, D. Amyotrophic lateral sclerosis and gene therapy. Nat Rev Neurol 2, 462–463 (2006).

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI:


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing